Putney Financial Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,414
Closed -$230K 85
2025
Q4
$230K Hold
2,414
0.22% 75
2025
Q3
$236K Sell
2,414
-200
-8% -$20.7K 0.23% 67
2025
Q2
$281K Sell
2,614
-1,040
-28% -$105K 0.28% 53
2025
Q1
$369K Hold
3,654
0.39% 42
2024
Q4
$326K Buy
+3,654
New +$322K 0.29% 53

Other funds holding BSX

Putney Financial Group's BSX Position: Q1 2026 in Review

Putney Financial Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,414 shares — an estimated $230K sold.

Putney Financial Group first reported a position in BSX in Q4 2024 and held it in 5 quarters. The position peaked at $369K in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Putney Financial Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Putney Financial Group sold 2,414 Boston Scientific shares in Q1 2026, an estimated $230K.
  • Putney Financial Group first reported a position in Boston Scientific in Q4 2024 and held it in 5 quarters.
  • Putney Financial Group's Boston Scientific position peaked at $369K in Q1 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Putney Financial Group's 13F filing for Q1 2026, filed 10 Apr 2026.